AtheroPharma Inc.
Overview
AtheroPharma Inc. is a biotechnology company focused on developing innovative therapies for cardiovascular diseases. Its research is centered around targeting atherosclerosis, with an aim to improve patients' quality of life through breakthrough treatments.
Therapeutic areas
CardiovascularAtherosclerosis
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to AtheroPharma Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.